|
Physiomics PLC on Friday said Christophe Chassagnole’s job title has changed from chief operating officer to chief scientific officer.
Physiomics is a London-based oncology consultancy, which uses mathematical models to support the development of cancer treatment regimens and personalised medicine solutions.
Physiomics explained that Chassagnole’s new title aligns more closely with his current role and responsibilities, as well as the expectation that, going forward, he will spend more time focused on the company’s personalised medicines initiatives.
It added that the change builds a board restructuring that has included bringing in two new non-executive directors last year.
Shares in Physiomics were down 1.4% to 3.90 pence each in London on Friday morning.
By Sophie Rose; Alliance News reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2023 Alliance News Ltd. All Rights Reserved.
|
